Trial intelligence / Profile preview

METTA – PRAGUE 10: Trimetazidine in Acute Heart Failure

2007-002893-76Phase 3Completed

Sponsor
Charles University
Start
Jul 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of trimetazidine in Acute Heart Failure (AHF) (2 arms), sponsored by Charles University. Primary endpoint: Troponin I level. Started Jul 2007; status: completed.

02

Drugs

trimetazidine
03

Conditions

Acute Heart Failure (AHF)

Beyond the preview

Go deeper on 2007-002893-76.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-002893-76.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call